Cone Health | Regional Center for Infectious Disease (RCID)

Research site

(Unclaimed)

Location

RCID Research 301 East Wendover Avenue, Ste 111, Greensboro, North Carolina, United States of America

Site insights

Top conditions

Top treatments

Diroximel Fumarate

Rovalpituzumab

Diuretic

Parent organization

This site is a part of Cone Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 18 total trials

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure (ALLEVIATE-HF)

The ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal...

Active, not recruiting

Heart Failure NYHA Class II

Heart Failure NYHA Class III

Device: Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download

Other: Medication intervention

Baroreflex Activation Therapy for Heart Failure (BeAT-HF)

The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therap...

Active, not recruiting

Heart Failure

Device: BAROSTIM NEO® System

Drug: Medical Management

BATwire Implant Kit

The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the Barostim System delivered...

Active, not recruiting

Heart Failure

Device: BATwire Implant Kit

Fluid Management of Acute Decompensated Heart Failure Subjects Treated with Reprieve Decongestion Management System (DMS) (FASTR)

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve DMS system to Optimal Diuretic Therapy (ODT...

Active, not recruiting

Acute Decompensated Heart Failure

Device: Reprieve Decongestion Management System

Drug: Diuretic

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

OPTIMISTmain is an investigator-initiated and conducted, international, multicentre, stepped wedge cluster randomized controlled trial comparing the...

Enrolling

Acute Ischemic Stroke Patients Receiving Reperfusion Therapy

Other: Low-intensity monitoring strategy

Other: Guideline recommended standard monitoring

RADIANCE Continued Access Protocol (RADIANCE CAP)

RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to...

Active, not recruiting

Hypertension

Hypertension, Resistant to Conventional Therapy

Device: Renal Denervation